This is an update to the 2014 Canadian Hereditary Angioedema Guideline with an
expanded scope to include the management of hereditary angioedema (HAE) patients …

Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and
effective therapy are critical. This revision and update of the global WAO/EAACI guideline on …

Hereditary Angioedema (HAE) is a rare and disabling disease. Early diagnosis and
appropriate therapy are essential. This update and revision of the global guideline for HAE …

This narrative review seeks to distinguish the clinical patterns of pre-existing allergic
conditions from other confounding non-allergic clinical entities, and to identify the potential …

Hereditary angioedema (HAE) is a disease which is associated with random and often
unpredictable attacks of painful swelling typically affecting the extremities, bowel mucosa …

Three types of hereditary angioedema (HAE) have been described: two are due to C1
inhibitor (C1-INH) deficiency (C1-INH-HAE types I and II) and one is characterized by normal …

Perioperative anaphylaxis is a life-threatening condition with an estimated prevalence of 1:
3,500 to 1: 20,000 procedures and a mortality rate of up to 9%. Clinical presentation involves …

In the vast majority of patients with hereditary angioedema (HAE), angioedema attacks are
due to the quantitative or functional deficiency of C1-esterase inhibitor (C1-INH), which …

This guideline is based on an informal consensus of experts that have been working in
Germany for a considerable time with patients with hereditary angioedema (HAE) due to a …

Patients with urticaria and angioedema often have triggers that cause an outbreak or a
swelling episode or worsen their chronic condition. Exploring these factors with each patient …